✦ LIBER ✦

Keloid formation after syndactyly release in patients with associated macrodactyly: management with methotrexate therapy

✍ Scribed by Tolerton, S. K.; Tonkin, M. A.

Book ID: 121404197
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 792 KB
Volume: 36
Category: Article
ISSN: 0363-5023
DOI: 10.1177/1753193411402146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics and management of cytopenias as

Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure

✍ Alfonso Quintás-Cardama; Fabio Pires De Souza Santos; Hagop Kantarjian; Susan O' 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

## Abstract ## BACKGROUND: The incidence, dynamics, and management of cytopenias were investigated in patients with chronic myeloid leukemia in chronic phase (CP CML) who received dasatinib therapy after imatinib failure. ## METHODS: Data were analyzed from 130 patients with CP CML who were trea

PCV15 COMBINED OPTIMAL LIPID VALUE GOAL

PCV15 COMBINED OPTIMAL LIPID VALUE GOAL ATTAINMENT AFTER TREATMENT INITIATION WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS EZETIMIBE PLUS SIMVASTATIN COMBINATION THERAPY IN A MANAGED CARE PATIENT POPULATION WITH PRIOR CARDIOVASCULAR DISEASE IN THE UNITED STATES

✍ S Balu; RA Quimbo; K Rodgers; RJ Simko; MJ Cziraky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCV74 PREDICTED REDUCTION IN HOSPITAL DA

PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

✍ RJ Simko; S Balu; SF Webb; R Quimbo; MJ Cziraky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB